Published : 01 Oct 2017
In September 2017, Aagami completed a busy and fruitful BioPharm America (BPA) 2017 conference with over 50 meetings. Dinesh Jain, CEO Aagami attended partnering meetings for Aagami and also for clients Aagami were representing during the event.
After BPA, Dinesh traveled for an extended business trip to New York and Connecticut along with a client for promotional meetings.
Also, along with its world class preclinical CRO client, Aagami conducted seminars on Futuristic Toxicology in collaboration with Rosalind Franklin University of Medical Sciences, Illinois Science and Technology Park and University of Connecticut.
Altogether, BPA and the extended trip proved to be very responsive and as a result many partnering possibilities are shaping up well.